Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Quarterly results Inv. presentation Consulting agrmnt
|
SYNERGY PHARMACEUTICALS, INC. (SGYP)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/16/2018 |
4
| Spigelman Melvin K (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 101,695 shares
@ $0 Exercised 150,000 options
@ $1.2, valued at
$180k
|
|
07/06/2018 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 27,785 shares
@ $0 Exercised 100,023 options
@ $0.5, valued at
$50k
|
|
07/06/2018 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 13,896 shares
@ $0 Exercised 50,023 options
@ $0.5, valued at
$25k
|
|
06/19/2018 |
4
| Spigelman Melvin K (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 114,750 options
@ $1.8, valued at
$206.6k
|
|
06/19/2018 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 114,750 options
@ $1.8, valued at
$206.6k
|
|
06/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/19/2018 |
4
| Joslyn Alan (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 114,750 options
@ $1.8, valued at
$206.6k
|
|
06/19/2018 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 114,750 options
@ $1.8, valued at
$206.6k
|
|
06/18/2018 |
4
| JACOB GARY S (Executive Chairman) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 131,934 shares
@ $0 Paid exercise price by delivering 150,246 shares
@ $0 Exercised 474,961 options
@ $0.5, valued at
$237.5k
|
|
04/02/2018 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Exercised 50,000 options
@ $0.5, valued at
$25k
|
|
01/23/2018 |
4
| Gemignani Gary G (Executive Vice Pres. & CFO) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 82,500 options
@ $2.4, valued at
$198k
|
|
01/09/2018 |
4
| Gemignani Gary G (Executive Vice Pres. & CFO) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 309,375 options
@ $2.18, valued at
$674.4k
|
|
01/09/2018 |
4
| JACOB GARY S (Executive Chairman) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 950,000 options
@ $2.18, valued at
$2.1M
|
|
01/09/2018 |
4
| Griffin Patrick (EVP and Chief Medical Officer) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 412,500 options
@ $2.18, valued at
$899.3k
|
|
01/09/2018 |
4
| Garcia Marino (EVP and Chief Strategy Officer) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 280,000 options
@ $2.18, valued at
$610.4k
|
|
01/09/2018 |
4
| Hamilton Troy (CEO) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 475,000 options
@ $2.18, valued at
$1M
|
|
12/19/2017 |
4
| Hamilton Troy (CEO) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 1,000,000 options
@ $2.01, valued at
$2M
|
|
11/14/2017 |
4
| PAULSON & CO. INC. (10% Owner) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Sold 8,750,000 shares
@ $2.8204, valued at
$24.7M
|
|
08/09/2017 |
4
| PAULSON & CO. INC. (10% Owner) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Sold 87 shares
@ $3.78, valued at
$328.9 Sold 26,200 shares
@ $3.765, valued at
$98.6k
Sold 220,000 options to buy
@ $3.813, valued at
$838.9k
|
|
06/30/2017 |
4
| Daly Richard J (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 62,500 options
@ $4.5, valued at
$281.3k
|
|
06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/30/2017 |
4
| ADAMS THOMAS PHD (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 62,500 options
@ $4.5, valued at
$281.3k
Disposed/sold 10,750 options
@ $1.4, valued at
$15.1k
Granted 10,750 options
@ $1.4, valued at
$15.1k
|
|
06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/30/2017 |
4
| Spigelman Melvin K (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 62,500 options
@ $4.5, valued at
$281.3k
Disposed/sold 12,000 options
@ $1.4, valued at
$16.8k
Granted 12,000 options
@ $1.4, valued at
$16.8k
|
|
06/30/2017 |
4
| Joslyn Alan (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 62,500 options
@ $4.5, valued at
$281.3k
Disposed/sold 26,500 options
@ $1.4, valued at
$37.1k
Granted 26,500 options
@ $1.4, valued at
$37.1k
|
|
06/30/2017 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 62,500 options
@ $4.5, valued at
$281.3k
Disposed/sold 14,000 options
@ $1.4, valued at
$19.6k
Granted 14,000 options
@ $1.4, valued at
$19.6k
|
|
05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/01/2017 |
4
| Gemignani Gary G (Executive Vice Pres. & CFO) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Granted 375,000 options
@ $4.12, valued at
$1.5M
|
|
01/06/2017 |
4
| PAULSON & CO. INC. (10% Owner) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Disposed of 226,187 options to buy
@ $6.6665, valued at
$1.5M
|
|
12/27/2016 |
4
| PAULSON & CO. INC. (10% Owner) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Disposed of 271,000 options to buy
@ $4.8285, valued at
$1.3M
Disposed of 144,000 options to buy
@ $5.712, valued at
$822.5k
|
|
11/08/2016 |
4
| PAULSON & CO. INC. (10% Owner) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Sold 140,000 shares
@ $4.2424, valued at
$593.9k
|
|
09/29/2016 |
4
| PAULSON & CO. INC. (10% Owner) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Sold 33,600 shares
@ $5.7458, valued at
$193.1k
Sold 20,700 shares
@ $5.6041, valued at
$116k
|
|
09/20/2016 |
4
| PAULSON & CO. INC. (10% Owner) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.
Txns:
| Sold 1,973,713 shares
@ $5.6113, valued at
$11.1M
Sold 1,500,000 shares
@ $5.61, valued at
$8.4M
|
|
|
|
|